Thulium Fiber Laser (TFL) Versus Holmium MOSES Laser for Ureteroscopic Management of Kidney Stones

Not Applicable

Recruiting

• Conditions: Kidney Stone
• Interventions: Device: MOSES Holmium Laser; Device: Thulium Fibre Laser

• Registration Number: NCT05598645
• Lead Sponsor: Thunder Bay Regional Health Research Institute

Brief Summary

This study aims to compare the efficacy and safety of both types of lasers, Holmium MOSES and TFL, in management of kidney stones requiring treatment.

Detailed Description

The prevalence of kidney stones has been increasing over the last two decades with lifetime recurrence risk reported to be as high as 50%. Holmium lasers are nowadays considered the "gold standard" for treatment of urinary tract stones.

Recently, the holmium laser urology platform from Lumenis has been updated to include a new technology called MOSES, which provides improved energy delivery of the laser to treat the stones, reduces migration of the stone during the procedure, and limits potential collateral tissue damage.

A new generation of lasers has evolved due to the advances in laser fiber technology, leading to the development of the Thulium Fiber Laser (TFL). TFL can operate within a large range of energy, frequency and pulse duration settings. The small fiber size is one of the main advantages of TFL, as it allows better endoscope performance through easier deflection and bigger working channel space. Furthermore, it produces small stone fragments and better dusting capabilities compared to the standard Holmium laser when adjusted on the same power settings.

This study will compare the efficacy and safety of Holmium MOSES and TFL in management of kidney stones requiring treatment.

Study Timeline

• Study Start: 2022-08-16
• Study First Submitted: 2022-10-25
• Study First Submitted QC: 2022-10-25
• Study First Posted: 2022-10-28
• Status Verified: 2024-08
• Last Update Submitted: 2024-08-06
• Last Update Posted: 2024-08-07
• Primary Completion: 2026-06
• Study Completion: 2026-09

Recruitment & Eligibility

• Status: RECRUITING
• Sex: All
• Target Recruitment: 174

Inclusion Criteria

1. 18 years of age and over at the time of enrollment.
2. Patients referred with single kidney stones of 10-20 mm in its largest diameter, or multiple stones involving a single calyx.
3. Written informed consent to participate in the study
4. Ability to comply with the requirements of the study procedures

Read More

Exclusion Criteria

1. Patients with ipsilateral distal ureteral stones or stricture.
2. Stone size > 20 mm or multiple kidney stones in different calyces.
3. Previous shock wave lithotripsy (SWL) treatment for the same stone.
4. Participants with active urinary tract infection until appropriately treated
5. Uncorrected coagulopathy (anticoagulants or blood thinners which cannot be withheld before surgery).
6. Pregnancy.
7. Participants with preexisting conditions, which, in the opinion of the investigator, interfere with the conduct of the study.
8. Participants who are uncooperative or cannot follow instructions.
9. Participants who lack the capacity, or cannot speak English, in order to provide free and informed written consent.
10. Patients with solitary kidney.

Read More

Study & Design

• Study Type: INTERVENTIONAL
• Study Design: PARALLEL

Arm && Interventions

Group	Intervention	Description
MOSES Holmium Laser	MOSES Holmium Laser	Patients randomized to this arm will undergo treatment using the MOSES Holmium laser.
Thulium Fibre Laser (TFL)	Thulium Fibre Laser	Patients randomized to this arm will undergo treatment using the TFL.

Primary Outcome Measures

Name	Time	Method
Procedural Time	Intraoperative	Measured in number of minutes from the insertion of the ureteroscope to the removal of the ureteroscope.

Secondary Outcome Measures

Name	Time	Method
Total operative time	Intraoperative	Measured in n minutes from the anesthesia induction until placement of the stent.
Lasing time	Intraoperative	Measured in minutes and defined as the time the laser was in use, not including pedal pauses.
Percentage of Patients with Post-op Complications	4 weeks	Percentage of patients that results with a post-op complication
Total energy used	Intraoperative	Measured in kilojoules, defined as energy used to fragment the stones into small pieces (≤2 mm).
Laser efficiency	Intraoperative	Measured as mm per minute and defined as the stone size (mm) that can be treated every minute; the cumulative stone size (adding the maximum size of each stone that is treated during the surgery) is divided by the lasering time.
Number of times the laser pedals are pressed	Intraoperative	Measured as a numerical value, defined as number of left, right, and total pedal presses
Stone Free Rate (SFR)	4 and 12 weeks post-op	SRF will be defined as the absence of any residual stone fragments or the presence of clinically insignificant residual stone fragments in the urinary tract which were defined as ˂4 mm, asymptomatic, non-obstructive and non-infectious stone particles.

Trial Locations

Locations (1)

Thunder Bay Regional Health Sciences Centre; 🇨🇦 Thunder Bay, Ontario, Canada